Halozyme Therapeutics, Lilly sign global collaboration and license agreement

[News]

Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.

More... (http://www.news-medical.net/news/20151221/Halozyme-Therapeutics-Lilly-sign-global-collaboration-and-license-agreement.aspx)